Lv1
100 积分 2020-07-03 加入
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
12天前
已完结
Evaluation of Discontinuation and Re-Initiation of Biologic Therapies in Psoriasis: Real-World Data
1个月前
已关闭
Quality of Life Benefit and Clinical Predictors of Complete Skin Clearance in Psoriasis: A Multicenter, Prospective, Real-World Study
1个月前
已完结
Disease modification in psoriasis through early interleukin 17 inhibitor intervention: A retrospective cohort study
1个月前
已完结
Early Response to Vunakizumab at Week 2 Predicts Favourable Long-Term Efficacy in Patients With Moderate-To-Severe Plaque Psoriasis: A Post Hoc Analysis of a Phase III, Randomised Controlled Trial
1个月前
已完结
Evaluating the economic burden of psoriasis in the United States
1个月前
已完结
The role of topical therapies along the psoriasis patient journey: An overview from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30(th) EADV Congress 2021
1个月前
已完结
Continued treatment with secukinumab is associated with high retention or regain of response
1个月前
已完结
Effectiveness and Safety of Switching Biologics after Secukinumab Treatment Failure in Moderate-to-Severe Plaque Psoriasis: A Retrospective Cohort Study
1个月前
已完结
Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering-an expert perspective
1个月前
已完结
皖公网安备34019202002308
